
MacroGenics, Inc.
@macrogenics
MacroGenics is discovering and
developing innovative monoclonal antibody-based therapeutics for the treatment of cancer.
ID: 190263900
http://www.macrogenics.com 13-09-2010 14:21:00
231 Tweet
525 Followers
35 Following






Living with metastatic HER2-positive breast cancer and not sure where to turn? Check out the MBC Alliance for information and support services. You can learn from others, share experiences and more: mbcalliance.org

SOPHIA trial results have been published in JAMA Oncology; these data describe a new treatment option for adults with metastatic HER2+ breast cancer. Read more here: ir.macrogenics.com/news-releases/…


We are happy to announce that MacroGenics, Inc. has decided to partner with Genedata to advance their translational and clinical research programs. Learn more on: bit.ly/GDMacroGenics #GenedataProfiler #ClinicalResearch #PrecisionMedicine #Immunotherapy



On Wednesday, Zai Lab Ltd. entered a deal with MacroGenics, Inc. Inc. covering up to four CD3- or CD47-based bispecifics. The expanded collaboration will give the Shanghai-based biotech broader Asia and worldwide rights to multiple cancer programs bit.ly/3wxgQdC $ZLAB $MGNX









New #JITC review: Role of Fcγ receptors in HER2-targeted breast cancer therapy bit.ly/3n1m6Uj Antonino Musolino Hope Rugo Fernanda Arnaldez William Gradishar, MD

